Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lantus
Pharma
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
The FTC chimed in on Mylan's insulin antitrust case against Sanofi, once again targeting alleged improper patent listings in the FDA's Orange Book.
Angus Liu
Nov 21, 2023 11:34am
Civica Rx draws $50M from California to produce low-cost insulin
Mar 20, 2023 11:45am
Bernie Sanders calls out Sanofi, Novo Nordisk for insulin prices
Mar 3, 2023 11:52am
FDA rejects Biocon biosimilar over data, manufacturing concerns
Jan 12, 2023 8:25am
Viatris kicked off its third insulin biosim recall this year
Jul 6, 2022 9:08am
Sanofi cuts insulin price for uninsured in US from $99 to $35
Jun 29, 2022 11:17am
